Detalhe da pesquisa
1.
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
Blood
; 137(1): 49-60, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693406
2.
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
Blood
; 135(26): 2375-2387, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299093
3.
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.
Mod Pathol
; 34(1): 59-69, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999413
4.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057357
5.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Blood
; 127(15): 1896-906, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755711
6.
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.
Blood Adv
; 7(1): 167-173, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240453
7.
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
J Clin Oncol
; 41(16): 3019-3031, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930848
8.
Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients-A EuroFlow Study.
Cancers (Basel)
; 14(8)2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454917
9.
Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study.
Blood Adv
; 6(3): 976-992, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814179
10.
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology.
Blood Adv
; 6(2): 690-703, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587246
11.
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.
J Clin Oncol
; 40(27): 3151-3161, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666958
12.
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638406
13.
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
Blood Cancer J
; 11(12): 202, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907159
14.
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.
Blood Cancer J
; 11(2): 34, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594045
15.
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.
Cancers (Basel)
; 13(7)2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916787
16.
Measurable residual disease in multiple myeloma: ready for clinical practice?
J Hematol Oncol
; 13(1): 82, 2020 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571377
17.
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.
Leukemia
; 34(11): 3007-3018, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32475991
18.
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.
Leukemia
; 34(2): 589-603, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595039
19.
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
J Clin Oncol
; 38(8): 784-792, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770060
20.
How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers.
J Immunol Methods
; 475: 112388, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154914